Related Experiment Video
Updated: Jun 24, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Sentinel node biopsy in head and neck squamous cell carcinoma.
Moni Abraham Kuriakose1, Nirav P Trivedi
1Head and Neck Institute, Amrita Institute of Medical Sciences and Research Centre, Kerala, India. mak12@nyu.edu
Summary
Sentinel lymph node biopsy (SNB) shows promise for staging head and neck cancer metastasis. However, it is currently investigational and requires further validation through randomized clinical trials before widespread adoption.
Area of Science:
- Oncology
- Surgical Pathology
- Head and Neck Cancer Research
Background:
- Sentinel lymph node biopsy (SNB) is an evolving technique for assessing neck node metastasis in head and neck cancers.
- Accurate staging of nodal basins is crucial for treatment planning.
Purpose of the Study:
- To systematically review the literature on SNB for head and neck cancer.
- To identify current limitations and outline future research directions.
Main Methods:
- Systematic review of published studies on SNB in head and neck cancer.
- Analysis of SLN localization techniques, pathological evaluation, and clinical applicability.
Main Results:
- Radiolabeled lymphoscintigraphy is superior to blue dye for SLN localization.
- SNB is recommended for early-stage (T1/2) oral cavity and oropharyngeal cancers with N0 stage.
- Current methods for intraoperative pathological confirmation of micrometastasis are not sensitive.
Conclusions:
- SNB in head and neck squamous cell carcinoma is currently investigational.
- Larger randomized clinical trials are needed for validation.
- SNB should not be recommended outside clinical trials at this time.
